Psychosocial Concerns in Patients Living with an Implantable Cardioverter Defibrillator

  • Ingela Thylén


Despite the unquestionable mortality advantages of implantable cardioverter defibrillators [ICDs], some patients with ICDs will experience psychosocial concerns after implantation, including symptoms of anxiety, depression, and post traumatic stress disorder, as well as ICD-related distress. Factors that can influence the impact of these psychological disorders include socio-demographic variables, variables related to the ICD and psychosocial variables. Unfortunately, it is uncommon for patients to seek help for their anxiety and depression. It is therefore of paramount importance that the healthcare professionals actively ask their patients about their psychological state during follow-up of the device. By discussing concerns and common reactions to the ICD, potential anxiety or depression can be prevented or alleviated.


Age Anxiety Depression Gender ICD shock ICD-related concerns Patient outcomes Personality traits Posttraumatic stress disorder Psychological distress Type-D personality 


  1. 1.
    Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl EA, Singh PP, et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res. 2011;71(4):223–31.PubMedCrossRefGoogle Scholar
  2. 2.
    Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsildis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med. 2006;21:30–8.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Moser DK, Dracup K, Evangelista LS, Zambroski CH, Lennie TA, Chung ML, et al. Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung. 2010;39:378–85.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002;87:488–93.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Pedersen SS, Theuns DA, Erdman RA, Jordaens L. Clustering of device-related concerns and type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol. 2008;31:20–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Stein D. Generalised anxiety disorder. Rethinking diagnosis and rating. CNS Spectr. 2005;10(12):930–4.PubMedCrossRefGoogle Scholar
  7. 7.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association (APA); 2013.CrossRefGoogle Scholar
  8. 8.
    Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RAM. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005;149(4):664–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Hegel MT, Griegel LE, Black C, et al. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. Int J Psychiatry Med. 1997;27:57–69.PubMedCrossRefGoogle Scholar
  10. 10.
    Ford J, Finch JF, Woodrow LK, Cutitta KE, Shea JA, Fischer A, et al. The Florida Shock Anxiety Scale (FSAS) for patients with implantable cardioverter defibrillators: testing factor structure, reliability, and validity of a previously established measure. Pacing Clin Electrophysiol. 2012;35:1146–53.PubMedCrossRefGoogle Scholar
  11. 11.
    Frizelle DJ, Lewin B, Kaye G, Moniz-Cook ED. Development of a measure of the concerns held by people with implanted cardioverter defibrillators: the ICDC. Br J Health Psychol. 2006;11:293–301.PubMedCrossRefGoogle Scholar
  12. 12.
    Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–92.PubMedCrossRefGoogle Scholar
  13. 13.
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.PubMedCrossRefGoogle Scholar
  15. 15.
    Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Derogatis LR. Brief Symptom Inventory (BSI)-18. Administration, scoring and procedures manual. Minneapolis: NCS Pearson; 2001.Google Scholar
  17. 17.
    von Kanel R, Baumert J, Kolb C, Cho EY, Ladwig KH. Chronic posttraumatic stress and its predictors in patients living with an implantable cardioverter defibrillator. J Affect Disord. 2011;131:344–52.CrossRefGoogle Scholar
  18. 18.
    Weiss DS, Marmar CR. The impact of event scale—revised. In: Wilson JP, Keane TM, editors. Assessing psychological trauma and PTSD. New York: Guilford Press; 1997. p. 399–411.Google Scholar
  19. 19.
    Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry. 2008;65:1324–30.PubMedCrossRefGoogle Scholar
  20. 20.
    Rahmawati A, Chishaki A, Sawatari H, Tsuchihashi-Makaya M, Ohtsuka Y, Nakai M, et al. Gender disparities in quality of life and psychological disturbance in patients with implantable cardioverter-defibrillators. Circ J. 2013;77:1158–65.PubMedCrossRefGoogle Scholar
  21. 21.
    Pedersen SS, Van Den Broek KC, Van Den Berg M, Theuns DA. Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: is there more to it than meets the eye? Pacing Clin Electrophysiol. 2010;33(12):1430–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med. 2005;67(1):89–97.PubMedCrossRefGoogle Scholar
  23. 23.
    James JE, Albarran JW, Tagney J. The experiences of ICD patients and their partners with regards to adjusting to an imposed driving ban: a qualitative study. Coron Health Care. 2001;5(2):80–8.CrossRefGoogle Scholar
  24. 24.
    Johansson I, Strömberg A. Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator: the patient perspective. J Cardiovasc Nurs. 2010;25(6):E1–E10.PubMedCrossRefGoogle Scholar
  25. 25.
    Schuster PM, Phillips S, Dillon DL, Tomich PL. The psychosocial and physiological experiences of patients with an implantable cardioverter defibrillator. Rehabil Nurs. 1998;23:30–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Pelletier D, Gallagher R, Mitten-Lewis S, McKinley S, Squire J. Australian implantable cardiac defibrillator recipients: quality-of-life issues. Int J Nurs Pract. 2002;8:68–74.PubMedCrossRefGoogle Scholar
  27. 27.
    Albarran JW, Tagney J, James JE. Partners of ICD patients: an exploratory study of their experiences. Eur J Cardiovasc Nurs. 2004;3:201–10.PubMedCrossRefGoogle Scholar
  28. 28.
    Eckert M, Jones T. How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families. Int J Nurs Pract. 2002;8:152–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Craney J, Powers M. Factors related to driving in persons with an implantable cardioverter defibrillator. Prog Cardiovasc Nurs. 1995;10:12–7.PubMedGoogle Scholar
  30. 30.
    Tagney J, James JE, Albarran JW. Exploring the patient’s experiences of learning to live with an implantable cardioverter defibrillator (ICD) from one UK Centre: a qualitative study. Eur J Cardiovasc Nurs. 2003;2:195–203.PubMedCrossRefGoogle Scholar
  31. 31.
    Baessler C, Murphy S, Gebhardt L, Tso T, Ellenbogen K, Leman R. Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). Am J Cardiol. 2005;95:665–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Sears SF, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol. 2003;26:107–11.PubMedCrossRefGoogle Scholar
  33. 33.
    Jenkins LS, Powell JL, Schron EB, McBurnie MA, Bosworth-Farrell S, Moore R, et al. Partner quality of life in the antiarrhythmics versus implantable defibrillators trial. J Cardiovasc Nurs. 2007;22:472–9.PubMedCrossRefGoogle Scholar
  34. 34.
    van den Broek KC, Habibović M, Pedersen SS. Emotional distress in partners of patients with an implantable cardioverter defibrillator: a systematic review and recommendations for future research. Pacing Clin Electrophysiol. 2010;33(12):1442–50.CrossRefGoogle Scholar
  35. 35.
    Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB, et al. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation. 2012;126(17):2146–72.PubMedCrossRefGoogle Scholar
  36. 36.
    Thylén I. Younger implantable cardioverter defibrillator (ICD) patients’ quality-of-life, psychosocial concerns, and experience of the device. The EuroHeartCare Congress 2014-04-04. Stavanger; 2014.Google Scholar
  37. 37.
    Friedmann E, Thomas SA, Inguito P, Kao CW, Metcalf M, Kelley FJ, et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2006;17:65–72.PubMedCrossRefGoogle Scholar
  38. 38.
    Vazquez LD, Kuhl EA, Shea JB, Kirkness A, Lemon J, Whalley D, et al. Age-specific differences in women with implantable cardioverter defibrillators: an international multi center study. Pacing Clin Electrophysiol. 2008;31:1528–34.PubMedCrossRefGoogle Scholar
  39. 39.
    Thylen I, Dekker RL, Jaarsma T, Stromberg A, Moser DK. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. J Psychosom Res. 2014;77(2):122–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Wójcicka M, Lewandowski M, Smolis-Bak E, Szwed H. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators. Kardiol Pol. 2008;66(10):1050–8.PubMedGoogle Scholar
  41. 41.
    Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol. 2006;29:619–26.PubMedCrossRefGoogle Scholar
  42. 42.
    Johansen JB, Pedersen SS, Spindler H, Andersen K, Nielsen JC, Mortensen PT. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients. Europace. 2008;10:545–51.PubMedCrossRefGoogle Scholar
  43. 43.
    Jacq F, Foulldrin G, Savoure A, Anselme F, Baguelin-Pinaud A, Cribier A, et al. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. Gen Hosp Psychiatry. 2009;31:266–73.PubMedCrossRefGoogle Scholar
  44. 44.
    Thylén I, Strömberg A, Lindberg R, Moser DK. Octo-nonagenerians’ outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study. Manuscript. 2017.Google Scholar
  45. 45.
    McDonough A. The experiences and concerns of young adults (18-40 years) living with an implanted cardioverter defibrillator (ICD). Eur J Cardiovasc Nurs. 2009;8(4):274–80.PubMedCrossRefGoogle Scholar
  46. 46.
    Larimer K, Durmus J, Florez E. Experiences of young adults with pacemakers and/or implantable cardioverter defibrillators. J Cardiovasc Nurs. 2016;31(6):517–22.PubMedCrossRefGoogle Scholar
  47. 47.
    Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Hoogwegt MT, Kupper N, Jordaens L, Pedersen SS, Theuns DA. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator. Europace. 2013;15:1468–74.PubMedCrossRefGoogle Scholar
  49. 49.
    Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49:2408–15.PubMedCrossRefGoogle Scholar
  50. 50.
    Theuns DA, Schaer BA, Soliman OI, Altmann D, Sticherling C, Geleijnse ML, et al. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace. 2011;13:62–9.PubMedCrossRefGoogle Scholar
  51. 51.
    van den Akker M, Buntinix F, Metsemakers JFM, Roos S, Knotterus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recureent diseases. J Clin Epidemiol. 1998;51:367–75.PubMedCrossRefGoogle Scholar
  52. 52.
    Brettschneider C, Leicht H, Bickel H, Dahlhaus A, Fuchs A, Gensichen J, et al. Relative impact of multimorbid chronic conditions on health-related quality of life—results from the multicare cohort study. PLoS One. 2013;8:e66742.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Chan PS, Birkmeyer JD, Krumholz HM, Spertus JA, Nallamothu BK. Racial and gender trends in the use of implantable cardioverter defibrillators among Medicare beneficiaries between 1997 and 2003. Congest Heart Fail. 2009;15:51–7.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119:1078–84.PubMedCrossRefGoogle Scholar
  55. 55.
    Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol. 2008;22:65–70.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Bhavnani SP, Pavuluri V, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, et al. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study. Pacing Clin Electrophysiol. 2013;36:878–84.PubMedCrossRefGoogle Scholar
  57. 57.
    van der Heijden AC, Thijssen J, Borleffs CJ, van Rees JB, Hoke U, van der Velde ET, et al. Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients. Heart. 2013;99:1244–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Miller J, Thylen I, Moser DK. Gender disparities in symptoms of anxiety, depression, and quality of life in defibrillator recipients. Pacing Clin Electrophysiol. 2015:1–11.Google Scholar
  59. 59.
    Brouwers C, van den Broek KC, Denollet J, Pedersen SS. Gender disparities in psychological distress and quality of life among patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2011;34:798–803.PubMedCrossRefGoogle Scholar
  60. 60.
    Morken IM, Norekval TM, Bru E, Larsen AI, Karlsen B. Perceptions of healthcare professionals’ support, shock anxiety, and device acceptance among implantable cardioverter defibrillator recipients. J Adv Nurs. 2014;70:2061–71.PubMedCrossRefGoogle Scholar
  61. 61.
    Habibovic M, van Den Broek KC, Theuns DA, Jordaens L, Alings M, van der Voort PH, et al. Gender disparities in anxiety and quality of life in patients with an implantable-cardioverter defibrillator. Europace. 2011;13:1723–30.PubMedCrossRefGoogle Scholar
  62. 62.
    Spindler H, Johansen JB, Andersen K, Mortensen P, Pedersen SS. Gender differences in anxiety and concerns about the cardioverter defibrillator. Pacing Clin Electrophysiol. 2009;32:614–21.PubMedCrossRefGoogle Scholar
  63. 63.
    Starrenburg A, Pedersen SS, van Den Broek KC, Kraaier K, Scholten M, van den Palen J. Gender differences in psychological distress and quality of life in patients with an ICD 1-year postimplant. Pacing Clin Electrophysiol. 2014;37:843–52.PubMedCrossRefGoogle Scholar
  64. 64.
    Marshall P, Ketchell A, Maclean J. Comparison of male and female psychological outcomes related to implantable cardioverter defibrillators (COMFORTID). Eur J Cardiovasc Nurs. 2012;11:313–21.PubMedCrossRefGoogle Scholar
  65. 65.
    Merchant FM, Jones P, Wehrenberg S, Lloyd MS, Saxon LA, Group TAS. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assoc. 2014;3:e001289.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    van der Heijden AC, Borleffs CJ, Buiten MS, Thijssen J, van Rees JB, Cannegieter SC, et al. The clinical course of patients with implantable cardioverter-defibrillators: extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm. 2015;12(6):1169–76.PubMedCrossRefGoogle Scholar
  67. 67.
    Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, et al. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. 2003;14(9):940–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Erkapic D, Sperzel J, Stiller S, Meltendorf U, Mermi J, Wegscheider K, et al. Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial – a prospective multicentre study. Eur Heart J. 2013;34(2):130–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NAI, Link MS. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2008;19:784–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.PubMedCrossRefGoogle Scholar
  71. 71.
    Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.PubMedCrossRefGoogle Scholar
  72. 72.
    Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation. 2004;110:2591–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52(7):541–50.PubMedCrossRefGoogle Scholar
  74. 74.
    Kamphuis HC, Verhoeven NW, Leeuw R, Derksen R, Hauer RN, Winnubst JA. ICD: a qualitative study of patient experience the first year after implantation. J Clin Nurs. 2004;13:1008–16.PubMedCrossRefGoogle Scholar
  75. 75.
    Carroll DL, Hamilton GA. Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock. Heart Lung. 2005;34:169–78.PubMedCrossRefGoogle Scholar
  76. 76.
    Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients’ attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol. 2000;23(6):934–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Thylén I, Moser DK, Chung ML, Miller J, Fluur C, Strömberg A. Are ICD recipients able to foresee if they want to withdraw therapy or deactivate defibrillator shocks? IJC Heart Vessels. 2013;1:22–31. doi: 10.1016/j.ijchv.2013.11.001.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung. 2004;33:176–82.PubMedCrossRefGoogle Scholar
  79. 79.
    Thylen I, Moser DK, Stromberg A, Dekker RA, Chung ML. Concerns about implantable cardioverter defibrillator shocks mediate the relationship between actual shocks and psychological distress. Europace. 2016;18(6):828–35. doi: 10.1093/europace/euv220. Epub August 31, 2015.PubMedCrossRefGoogle Scholar
  80. 80.
    Morken IM, Isaksen K, Karlsen B, Norekvål TM, Bru E, Larsen A. Shock anxiety among implantable cardioverter defibrillator recipients with recent tachyarrhythmia. Pacing Clin Electrophysiol. 2012;35:1369–76.PubMedCrossRefGoogle Scholar
  81. 81.
    Palacios-Ceña D, Losa-Iglesias ME, Alvarez-López C, Cachón-Pérez M, Reyes RA, Salvadores-Fuentes P, et al. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review. J Adv Nurs. 2011;67(12):2537–50.PubMedCrossRefGoogle Scholar
  82. 82.
    Schulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety. Heart Lung. 2013;42:105–11.PubMedCrossRefGoogle Scholar
  83. 83.
    Crossmann A, Pauli P, Dengler W, Kuhlkamp V, Wiedemann G. Stability and cause of anxiety in patients with an implantable cardioverter defibrillator: a longitudinal two-year follow-up. Heart Lung. 2007;36:87–95.PubMedCrossRefGoogle Scholar
  84. 84.
    Freedenberg V, Thomas SA, Friedmann E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Fail Clin. 2011;7:59–68.PubMedCrossRefGoogle Scholar
  85. 85.
    Kapa S, Rotondi-Trevisan D, Mariano Z, Aves T, Irvine J, Dorian P. Pyschopathology in patients with ICDs over time: results of a prospective study. Pacing Clin Electrophysiol. 2010;33:198–208.PubMedCrossRefGoogle Scholar
  86. 86.
    Groeneveld PW, Matta MA, Suh JJ, Yang F, Shea JA. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era. Pacing Clin Electrophysiol. 2007;30(4):463–71.PubMedCrossRefGoogle Scholar
  87. 87.
    Bostwick JM, Sola CL. An updated review of implantable cardioverter defibrillators, induced anxiety, and quality of life. Psychiatr Clin North Am. 2007;30:677–88.PubMedCrossRefGoogle Scholar
  88. 88.
    Eifert GH, Zvolensky MJ, Lejuez CW. Heart-focused anxiety and chest pain: a conceptual and clinical review. Clin Psychol Sci Pract. 2000;7:403–17.CrossRefGoogle Scholar
  89. 89.
    Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5):589–94.PubMedCrossRefGoogle Scholar
  90. 90.
    van Ittersum M, de Greef M, van Gelder I, Coster J, Brügemann J, van der Schans C. Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator. Int J Rehabil Res. 2003;26(2):117–22.PubMedCrossRefGoogle Scholar
  91. 91.
    Berg SK, Pedersen BD, Svendsen JH, Zwisler AD, Kristensen L, Pedersen PU. COPE-ICD: patient experience of participation in an ICD specific rehabilitation programme. Eur J Cardiovasc Nurs. 2012;11(2):207–15.PubMedCrossRefGoogle Scholar
  92. 92.
    Sears SF, Serber ES, Lewis TS, Walker RL, Conners N, Lee JT, Curtis AB, Conti JB. Do positive health expectations and optimism relate to quality of life outcomes in ICD patients? J Cardiopulm Rehab. 2004;24:324–331.Google Scholar
  93. 93.
    Sears SF, Shea JB, Conti JB. How to respond to an implantable cardioverter defibrillator shock. Circulation. 2005;111:e380–2.Google Scholar
  94. 94.
    Pedersen SS, Sears SF, Burg MM, van den Broek KC. Does ICD indication affect quality of life and levels of distress? Pacing Clin Electrophysiol. 2009;32:153–6.PubMedCrossRefGoogle Scholar
  95. 95.
    Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RAM, Jordaens L. Type D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace. 2007;9(8):675–80.PubMedCrossRefGoogle Scholar
  96. 96.
    Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces shock thErapies (PainFREE Rx II) Trial. Circulation. 2005;111:2898–905.PubMedCrossRefGoogle Scholar
  97. 97.
    Sears SF, Hauf JD, Kirian K, Hazelton G, Conti JB. Posttraumatic stress and the implantable cardioverter defibrillator patient: what the electrophysiologist needs to know. Circ Arrhythm Electrophysiol. 2011;2011:242–50.CrossRefGoogle Scholar
  98. 98.
    Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, et al. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol. 2009;32:1259–71.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    van den Broek KC, Nyklicek I, Van der Voort PH, Alings M, Denollet J. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol. 2008;31:850–7.PubMedCrossRefGoogle Scholar
  100. 100.
    Thomas SA, Friedmann E, Gottlieb SS, Liu F, Morton PG, Chapa DW, et al. Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. Heart Lung. 2009;38:109–20.PubMedCrossRefGoogle Scholar
  101. 101.
    Pedersen SS, Van den Broek KC, Erdman RAM, Jordaens L, Theuns DAMJ. Pre-implantation implantable cardioverter defibrillator concerns and type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace. 2010;12(10):1446–52.PubMedCrossRefGoogle Scholar
  102. 102.
    van den Broek KC, Nyklícek I, Van der Voort PH, Alings M, Meijer A, Denollet J. Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients. J Am Coll Cardiol. 2009;54(6):531–7.PubMedCrossRefGoogle Scholar
  103. 103.
    Denollet J, Tekle FB, Pedersen SS, Van der Voort PH, Alings M, Van den Broek KC. Prognostic importance of distressed (type D) personality and shocks in patients with an implantable cardioverter defibrillator. Int J Cardiol. 2013;167(6):2705–9.PubMedCrossRefGoogle Scholar
  104. 104.
    Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, et al. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation. 2004;109:1386–91.PubMedCrossRefGoogle Scholar
  105. 105.
    Dunbar SB, Kimble LP, Jenkins LS, et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety. 1999;9:163–8.PubMedCrossRefGoogle Scholar
  106. 106.
    Burg MM, Lampert R, Joska T, et al. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med. 2004;66:898–902.PubMedCrossRefGoogle Scholar
  107. 107.
    Fries R, Konig J, Schafers HJ, et al. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin Cardiol. 2002;25:474–8.PubMedCrossRefGoogle Scholar
  108. 108.
    Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD, Poole-Wilson PA. Autonomic imbalance and immune activation in chronic heart failure—pathophysiological links. Cardiovasc Res. 2006;70(3):434–45.PubMedCrossRefGoogle Scholar
  109. 109.
    Carpeggiani C, Emdin M, Bonaguidi F, Landi P, Michelassi C, Trivella MG, et al. Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction. Eur Heart J. 2005;26(16):1612–7.PubMedCrossRefGoogle Scholar
  110. 110.
    Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med. 2005;165(13):1486–91.PubMedCrossRefGoogle Scholar
  111. 111.
    Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med. 1997;59(3):231–5.PubMedCrossRefGoogle Scholar
  112. 112.
    Martens EJ, Nyklíček I, Szabó BM, Kupper N. Depression and anxiety as predictors of heart rate variability after myocardial infarction. Psychol Med. 2008;38(03):375–83.PubMedCrossRefGoogle Scholar
  113. 113.
    Stein PK, Domitrovich PP, Huikuri HV, Kleiger RE. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol. 2005;16:13–20.PubMedCrossRefGoogle Scholar
  114. 114.
    Francis JL, Weinstein AA, Krantz DS, Haigney MC, Stein PK, Stone PH, et al. Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators. Psychosom Med. 2009;71(8):821–7.PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Hoogwegt MT, Pedersen SS, Theuns DA, Kupper N. Relation between emotional distress and heart rate variability in patients with an implantable cardioverter-defibrillator. Psychophysiology. 2014;51(2):187–96.PubMedCrossRefGoogle Scholar
  116. 116.
    van den Broek KC, Tekle FB, Habibović M, Alings M, van der Voort PH, Denollet J. Emotional distress, positive affect, and mortality in patients with an implantable cardioverter defibrillator. Int J Cardiol. 2013;165(2):327–32.PubMedCrossRefGoogle Scholar
  117. 117.
    Kao CW, Friedmann E, Thomas SA. Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Qual Life Res. 2010;19:307–15.PubMedCrossRefGoogle Scholar
  118. 118.
    Whang W, Albert CM, Sears SF, et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol. 2005;45:1090–5.PubMedCrossRefGoogle Scholar
  119. 119.
    Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111–21.PubMedCrossRefGoogle Scholar
  120. 120.
    Pedersen SS, Knudsen C, Dilling K, Sandgaard N, Brock Johansen JB. Living with an implantable cardioverter defibrillator: patients’ preferences and needs for information provision and care options. Europace 2016 Jun 5. pii: euw109. [Epub ahead of print] Scholar
  121. 121.
    Sears SF, Sowell LD, Kuhl EA, Kovacs AH, Serber ER, Handberg E, et al. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol. 2007;30:858–64.PubMedCrossRefGoogle Scholar
  122. 122.
    Lane DA, Aguinaga L, Blomström-Lundqvist C, Boriani G, Dan GA, Hills MT, et al. Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 2015;17(12):1747–69. doi: 10.1093/europace/euv233.PubMedCrossRefGoogle Scholar
  123. 123.
    Stromberg A, Fluur C, Miller J, Chung ML, Moser DK, Thylen I. ICD recipients’ understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life. Pacing Clin Electrophysiol. 2014;37(7):834–42.PubMedCrossRefGoogle Scholar
  124. 124.
    Groarke J, Beirne A, Buckley U, O’Dwyer E, Sugrue D, Keelan T, et al. Deficiencies in patients’ comprehension of implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol. 2012;35:1097–102.PubMedCrossRefGoogle Scholar
  125. 125.
    Yuhas J, Mattocks K, Gravelin L, Remetz M, Foley J, Fazio R, et al. Patients’ attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis. Pacing Clin Electrophysiol. 2012;35:1179–87.PubMedCrossRefGoogle Scholar
  126. 126.
    Dickerson SS, Posluszny M, Kennedy MC. Help seeking in a support group for recipients of implantable cardioverter defibrillators and their support persons. Heart Lung. 2000;29(2):87–96.PubMedCrossRefGoogle Scholar
  127. 127.
    Sears SFJ, Burns JL, Handberg E, Sotile WM, Conti JB. Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol. 2001;24(7):1113–7.PubMedCrossRefGoogle Scholar
  128. 128.
    Chevalier P, Cottraux J, Mollard E, Sai N, Brun S, Burri H, et al. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J. 2006;151(1):191.e1–6.CrossRefGoogle Scholar
  129. 129.
    Irvine J, Firestone J, Ong L, Cribbie R, Dorian P, Harris L, et al. A randomized controlled trial of cognitive behavior therapy tailored to psychological adaptation to an implantable cardioverter defibrillator. Psychosom Med. 2011;73(3):226–33.PubMedCrossRefGoogle Scholar
  130. 130.
    Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients’ long-term adjustment to the ICD: a prospective study. Pacing Clin Electrophysiol. 2000;23:450–6.PubMedCrossRefGoogle Scholar
  131. 131.
    Maia AC, Braga AA, Soares-Filho G, Pereira V, Nardi AE, Silva AC. Efficacy of cognitive behavioral therapy in reducing psychiatric symptoms in patients with implantable cardioverter defibrillator: an integrative review. Braz J Med Biol Res. 2014;47(4):265–72.PubMedPubMedCentralCrossRefGoogle Scholar
  132. 132.
    Qintar M, George JJ, Panko M, Bea S, Broer KA, St John J, et al. A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety. J Interv Card Electrophysiol. 2015;43(1):65–75.PubMedCrossRefGoogle Scholar
  133. 133.
    Cramer H, Lauche R, Haller H, Dobos G, Michalsen A. A systematic review of yoga for heart disease. Eur J Prev Cardiol. 2015;22(3):284–95.PubMedCrossRefGoogle Scholar
  134. 134.
    Freedenberg VA, Thomas SA, Friedmann E. A pilot study of a mindfulness based stress reduction program in adolescents with implantable cardioverter defibrillators or pacemakers. Pediatr Cardiol. 2015;36(4):786–95.PubMedCrossRefGoogle Scholar
  135. 135.
    Toise SC, Sears SF, Schoenfeld MH, Blitzer ML, Marieb MA, Drury JH, et al. Psychosocial and cardiac outcomes of yoga for ICD patients: a randomized clinical control trial. Pacing Clin Electrophysiol. 2014;37(1):48–62.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Cardiology and Department of Medical and Health SciencesLinköping UniversityLinköpingSweden

Personalised recommendations